Xinxin Pang

Zhengzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Correction: Tenascin‑C promotes the proliferation and fibrosis of mesangial cells in diabetic nephropathy through the β‑catenin pathway.

Correction: Tenascin‑C promotes the proliferation and fibrosis of mesangial cells in diabetic nephropathy through the β‑catenin pathway.

Journal: International urology and nephrology

Published: August 10, 2026

Immune-metabolic interactions shape the fibrotic landscape of diabetic kidney disease: emerging mechanisms and therapeutic prospects.

Immune-metabolic interactions shape the fibrotic landscape of diabetic kidney disease: emerging mechanisms and therapeutic prospects.

Journal: Frontiers in physiology

Published: November 04, 2025

Mechanistic insights into Shenqi Dihuang decoction in the treatment of immunoglobulin a nephropathy.

Mechanistic insights into Shenqi Dihuang decoction in the treatment of immunoglobulin a nephropathy.

Journal: Frontiers in pharmacology

Published: September 27, 2025

Immune Landscape in Kidney Transplantation.

Immune Landscape in Kidney Transplantation.

Journal: Journal of inflammation research

Published: July 11, 2025

Development and External Validation of a Nomogram for Predicting the Effect of RTX on the Treatment of Membranous Nephropathy.

Development and External Validation of a Nomogram for Predicting the Effect of RTX on the Treatment of Membranous Nephropathy.

Journal: Journal of inflammation research

Published: June 29, 2023

CMKLR1 Antagonist Alpha-NETA Protects against Diabetic Nephropathy in Mice.

CMKLR1 Antagonist Alpha-NETA Protects against Diabetic Nephropathy in Mice.

Journal: Kidney & blood pressure research

Published: September 22, 2022

Tenascin-C promotes the proliferation and fibrosis of mesangial cells in diabetic nephropathy through the β-catenin pathway.

Tenascin-C promotes the proliferation and fibrosis of mesangial cells in diabetic nephropathy through the β-catenin pathway.

Journal: International urology and nephrology

Published: July 12, 2022

Hirudin ameliorates diabetic nephropathy by inhibiting Gsdmd-mediated pyroptosis.

Hirudin ameliorates diabetic nephropathy by inhibiting Gsdmd-mediated pyroptosis.

Journal: Cell biology and toxicology

Published: March 29, 2021

Tongluo Digui decoction treats renal injury in diabetic rats by promoting autophagy of podocytes.

Tongluo Digui decoction treats renal injury in diabetic rats by promoting autophagy of podocytes.

Journal: Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan

Published: February 01, 2021

Ginkgo Biloba Extract EGB761 Ameliorates the Extracellular Matrix Accumulation and Mesenchymal Transformation of Renal Tubules in Diabetic Kidney Disease by Inhibiting Endoplasmic Reticulum Stress.

Ginkgo Biloba Extract EGB761 Ameliorates the Extracellular Matrix Accumulation and Mesenchymal Transformation of Renal Tubules in Diabetic Kidney Disease by Inhibiting Endoplasmic Reticulum Stress.

Journal: BioMed research international

Published: October 28, 2020

Ameliorative role of SIRT1 in peritoneal fibrosis: an in vivo and in vitro study.

Ameliorative role of SIRT1 in peritoneal fibrosis: an in vivo and in vitro study.

Journal: Cell & bioscience

Published: June 15, 2020

Hirudin Reduces the Expression of Markers of the Extracellular Matrix in Renal Tubular Epithelial Cells in a Rat Model of Diabetic Kidney Disease Through the Hypoxia-Inducible Factor-1α (HIF-1α)/Vascular Endothelial Growth Factor (VEGF) Signaling Pathway.

Hirudin Reduces the Expression of Markers of the Extracellular Matrix in Renal Tubular Epithelial Cells in a Rat Model of Diabetic Kidney Disease Through the Hypoxia-Inducible Factor-1α (HIF-1α)/Vascular Endothelial Growth Factor (VEGF) Signaling Pathway.

Journal: Medical science monitor : international medical journal of experimental and clinical research

Published: May 31, 2020

Showing 1-12 of 16

Last Updated: 09/26/2026